Open AccessEfficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia
Author(s) -
Natalia Ilyina,
Anton S Edin,
N. Astafieva,
А С Лопатин,
Irina Sidorenko,
О П Уханова,
Ф. М. Ханова
Publication year - 2019
Publication title -
international archives of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.696
H-Index - 100
eISSN - 1423-0097
pISSN - 1018-2438
DOI - 10.1159/000494507
Subject(s) - fluticasone propionate , azelastine , nasal spray , nasal administration , fluticasone , medicine , hydrochloride , asthma , immunology , anesthesia , pharmacology , chemistry , organic chemistry
The novel intranasal formulation of azelastine hydrochloride (AZE) and fluticasone propionate (FP) in a single spray (MP-AzeFlu) was compared with a first-line intranasal antihistamine spray (AZE) in Russian seasonal allergic rhinitis (SAR) patients.